Skip to main content
DNA Labs India

CCNO Gene Primary ciliary dyskinesia type 29 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CCNO Gene Primary ciliary dyskinesia type 29 NGS Genetic Test

Short Name: CCNO Gene PCD Type 29 NGS Test

Also known as: Primary Ciliary Dyskinesia Type 29 Genetic Test, CCNO Gene Test, PCD Type 29 NGS Test

CCNO Gene Primary ciliary dyskinesia type 29 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

✍️ Written By

🩺 Medically Reviewed By

Dr Pasupathy Arumugam

Dr Pasupathy Arumugam

Consultant Pathologist · Reg: 21521

Last reviewed: September 7, 2026

Overview

The purpose of this test is to detect mutations in the CCNO gene and other genes associated with Primary Ciliary Dyskinesia type 29 using NGS technology. It aids in confirming diagnosis, guiding treatment, and providing genetic counseling for affected individuals and families.

Test Code
4785
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation required. Provide clinical history and genetic counseling session.

Method: Venipuncture or FTA Card

Step 2

Laboratory Analysis

Blood sample collected via venipuncture or one drop on FTA card by trained phlebotomist.

Step 3

Report Delivery

Apply pressure to the puncture site. Store sample as per instructions for stability.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Provide clinical history and undergo genetic counseling. No fasting required.
2
During the Test:Blood sample collection takes a few minutes. Minimal discomfort.
3
After the Test:Resume normal activities. Report delivery in 3-4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to detect mutations in the CCNO gene and other genes associated with Primary Ciliary Dyskinesia type 29 using NGS technology. It aids in confirming diagnosis, guiding treatment, and providing genetic counseling for affected individuals and families.

How to Prepare

  • Ensure proper identification of patient
  • Use sterile equipment
  • Label samples correctly
  • Transport at ambient temperature

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic testing for Primary Ciliary Dyskinesia is essential for accurate diagnosis, guiding management, and informing family planning. Early detection can help prevent respiratory complications and improve quality of life."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Collection MethodVenipuncture or FTA Card

Sample Stability

Blood: 2-8°C for 7 days
FTA Card: Room temperature for months
Sample Rejection Criteria:
  • Hemolyzed sample
  • Insufficient volume
  • Incorrect labeling

Understanding Your Results

Results indicate the presence or absence of pathogenic variants in the CCNO gene. Positive results confirm genetic basis for PCD, while negative results may require further testing.
📊

Pathogenic variant detected

Confirms diagnosis of PCD type 29. Genetic counseling recommended.

📊

No pathogenic variant detected

PCD type 29 unlikely, but clinical correlation needed. Consider other genetic tests.

📊

Variant of uncertain significance

Further family studies or functional analysis may be required.

⚠️ When to Consult a Doctor:

Consult a geneticist or ENT specialist if symptoms persist or if there is a family history of PCD. Discuss results for management and family planning.

Limitations

  • ⚠May not detect all genetic variants
  • ⚠Results require clinical correlation
  • ⚠Limited to known PCD genes

Risks & Considerations

  • ●Minimal risk from blood draw
  • ●Psychological impact of genetic results

Interfering Factors

  • ●Sample contamination
  • ●Degraded DNA
  • ●Incorrect sample type

Frequently Asked Questions

What is the CCNO Gene Primary Ciliary Dyskinesia Type 29 NGS Genetic Test?
It is a genetic test that uses Next-Generation Sequencing to analyze the CCNO gene for mutations causing PCD type 29.
Who should take this test?
Individuals with symptoms like chronic cough, recurrent sinus infections, or infertility, and those with a family history of PCD.
What is the cost of the test?
The test costs INR 20,000 at DNA Labs India, with free home sample collection.
How is the sample collected?
A blood sample is collected via venipuncture or one drop on an FTA card by a trained professional.
Is fasting required for the test?
No, fasting is not required for this genetic test.
How long does it take to get results?
Results are typically available in 3 to 4 weeks.
What does a positive result mean?
A positive result indicates pathogenic variants in the CCNO gene, confirming PCD type 29 diagnosis.
Can this test detect all types of PCD?
No, it focuses on CCNO gene and related genes; other PCD genes may require separate tests.
Is home sample collection available?
Yes, free home collection is available in many cities across India.
What should I do after receiving results?
Consult a geneticist or ENT specialist for interpretation, management, and genetic counseling.
Are there any risks associated with the test?
Risks are minimal, primarily from blood draw, but psychological impact of results should be considered.
Is the test covered by insurance?
Coverage depends on your insurance policy; check with your provider for details.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

Connexin 30 Mutation Detection Test

₹8,000

COL4A3 Gene Alport syndrome, autosomal recessive NGS Genetic Test

₹20,000

PLCB4 Gene Auriculocondylar syndrome type 2 NGS Genetic Test

₹20,000

DIAPH3 Gene Auditory neuropathy, autosomal dominant NGS Genetic Test

₹20,000

MYO7A Gene Deafness, autosomal dominant type 11 NGS Genetic Test

₹20,000

POU4F3 Gene Deafness, autosomal dominant type 15 NGS Genetic Test

₹20,000
For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.